Form 13F-HR RTW INVESTMENTS, LP For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
May 16, 2022 11:16 AM EDT
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
The reader should not assume that the information is accurate
and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average burden |
| hours per response: |
23.8 |
|
|
| Report for the Calendar Year or Quarter Ended: |
03-31-2022 |
| Check here if Amendment |
|
Amendment Number: |
|
| This Amendment (Check only one.): |
|
is a restatement. |
|
|
adds new holdings entries. |
| Institutional Investment Manager Filing
this Report: |
| Name: |
RTW INVESTMENTS, LP |
| Address: |
40 10th Avenue |
|
7th Floor |
|
|
|
NEW YORK
,
NY10014
|
| Form 13F File Number: |
028-16670 |
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all information
contained herein is true, correct and complete, and that it is
understood that all required items, statements, schedules, lists, and
tables, are considered integral parts of this form.
| Person Signing this Report on Behalf of
Reporting Manager: |
| Name: |
Roderick Wong |
| Title: |
Managing Partner |
| Phone: |
646-597-6980 |
| Signature, Place, and Date of Signing: |
| /s/ Roderick Wong |
New York
,
NY
|
05-16-2022 |
| [Signature] |
[City, State] |
[Date] |
|
| Report Type (Check only one.): |
| X |
13F HOLDINGS REPORT. (Check here if all holdings of
this reporting manager are reported in this report.) |
|
|
13F NOTICE. (Check here if no holdings reported are in
this report, and all holdings are reported by other reporting
manager(s).) |
|
|
13F COMBINATION REPORT. (Check here if a portion of
the holdings for this reporting manager are reported in this
report and a portion are reported by other reporting manager(s).) |
| Form 13F Summary Page |
|
Report Summary: |
|
Number of Other Included
Managers: |
3 |
|
|
|
Form 13F Information Table Entry Total: |
106 |
|
Form 13F Information Table Value Total: |
4,831,643 |
|
(thousands) |
|
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
|
|
|
Form 13F File Number |
Name |
|
028-16671 |
RTW MASTER FUND, LTD. |
|
028-19525 |
RTW Innovation Master Fund Ltd. |
|
028-19571 |
RTW Venture Fund Ltd |
| List of Other Included
Managers: |
|
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the
manager filing this report.
|
|
[If there are no entries in this list, state “NONE” and omit the
column headings and list entries.]
|
|
No. |
Form 13F File Number |
Name |
|
1 |
028-16671 |
RTW MASTER FUND, LTD. |
|
2 |
028-19525 |
RTW Innovation Master Fund Ltd. |
|
3 |
028-19571 |
RTW Venture Fund Ltd |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
The reader should not assume that the information is
accurate and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F INFORMATION TABLE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average
burden |
| hours per response:
|
23.8 |
|
|
| COLUMN 1 |
COLUMN 2 |
COLUMN 3 |
COLUMN 4 |
COLUMN 5 |
COLUMN 6 |
COLUMN 7 |
COLUMN 8 |
|
|
|
VALUE |
SHRS OR |
SH/ |
PUT/ |
INVESTMENT |
OTHER |
VOTING AUTHORITY |
| NAME OF ISSUER |
TITLE OF CLASS |
CUSIP |
(x$1000) |
PRN AMT |
PRN |
CALL |
DISCRETION |
MANAGER |
SOLE |
SHARED |
NONE |
| 10X GENOMICS INC |
CL A COM |
88025U109 |
55,872 |
734,481 |
SH |
|
SOLE |
1,2,3 |
734,481 |
0 |
0 |
| 2SEVENTY BIO INC |
COMMON STOCK |
901384107 |
20,975 |
1,229,508 |
SH |
|
SOLE |
1,2,3 |
1,229,508 |
0 |
0 |
| 5 01 ACQUISITION CORP |
COM CL A |
33836P105 |
3,861 |
392,000 |
SH |
|
SOLE |
1,2,3 |
392,000 |
0 |
0 |
| 908 DEVICES INC |
COM |
65443P102 |
760 |
40,000 |
SH |
|
SOLE |
1,2,3 |
40,000 |
0 |
0 |
| AADI BIOSCIENCES INC |
COM |
00032Q104 |
12,977 |
764,701 |
SH |
|
SOLE |
1,2,3 |
764,701 |
0 |
0 |
| ADICET BIO INC |
COM |
007002108 |
59,700 |
2,989,482 |
SH |
|
SOLE |
1,2,3 |
2,989,482 |
0 |
0 |
| ADVERUM BIOTECHNOLOGIES INC |
COM |
00773U108 |
293 |
223,725 |
SH |
|
SOLE |
1,2,3 |
223,725 |
0 |
0 |
| AGENUS INC |
COM NEW |
00847G705 |
8,813 |
3,582,481 |
SH |
|
SOLE |
1,2,3 |
3,582,481 |
0 |
0 |
| AKOYA BIOSCIENCES INC |
COM |
00974H104 |
854 |
77,676 |
SH |
|
SOLE |
1,2,3 |
77,676 |
0 |
0 |
| ALNYLAM PHARMACEUTICALS INC |
COM |
02043Q107 |
274,876 |
1,683,362 |
SH |
|
SOLE |
1,2,3 |
1,683,362 |
0 |
0 |
| APELLIS PHARMACEUTICALS INC |
COM |
03753U106 |
2,601 |
51,194 |
SH |
|
SOLE |
1,2,3 |
51,194 |
0 |
0 |
| APOLLO ENDOSURGERY INC |
COM |
03767D108 |
1,561 |
258,064 |
SH |
|
SOLE |
1,2,3 |
258,064 |
0 |
0 |
| APYX MEDICAL CORPORATION |
COM |
03837C106 |
22,191 |
3,398,279 |
SH |
|
SOLE |
1,2,3 |
3,398,279 |
0 |
0 |
| ARGENX SE |
SPONSORED ADR |
04016X101 |
106,253 |
336,978 |
SH |
|
SOLE |
1,2,3 |
336,978 |
0 |
0 |
| ARYA SCIENCES ACQU CORP IV |
CL A |
G31659108 |
4,900 |
500,000 |
SH |
|
SOLE |
1,2,3 |
500,000 |
0 |
0 |
| ARYA SCIENCES ACQUISITN CORP |
CLASS A ORD SHS |
G31658100 |
4,855 |
500,000 |
SH |
|
SOLE |
1,2,3 |
500,000 |
0 |
0 |
| ASLAN PHARMACEUTICALS LTD |
ADS |
04522R101 |
2,924 |
3,250,000 |
SH |
|
SOLE |
1,2,3 |
3,250,000 |
0 |
0 |
| ATHIRA PHARMA INC |
COM |
04746L104 |
25,739 |
1,906,557 |
SH |
|
SOLE |
1,2,3 |
1,906,557 |
0 |
0 |
| AVADEL PHARMACEUTICALS PLC |
SPONSORED ADR |
05337M104 |
39,217 |
5,741,939 |
SH |
|
SOLE |
1,2,3 |
5,741,939 |
0 |
0 |
| AVIDITY BIOSCIENCES INC |
COM |
05370A108 |
88,564 |
4,795,000 |
SH |
|
SOLE |
1,2,3 |
4,795,000 |
0 |
0 |
| AVITA MEDICAL INC |
COM |
05380C102 |
905 |
106,667 |
SH |
|
SOLE |
1,2,3 |
106,667 |
0 |
0 |
| AXONICS INC |
COM |
05465P101 |
109,166 |
1,743,864 |
SH |
|
SOLE |
1,2,3 |
1,743,864 |
0 |
0 |
| AXSOME THERAPEUTICS INC |
COM |
05464T104 |
67,003 |
1,618,819 |
SH |
|
SOLE |
1,2,3 |
1,618,819 |
0 |
0 |
| BCLS ACQUISITION CORP |
COM CL A |
G0904B105 |
6,045 |
612,500 |
SH |
|
SOLE |
1,2,3 |
612,500 |
0 |
0 |
| BICYCLE THERAPEUTICS PLC |
SPONSORED ADS |
088786108 |
56,003 |
1,276,276 |
SH |
|
SOLE |
1,2,3 |
1,276,276 |
0 |
0 |
| BRAINSWAY LTD |
SPONSORED ADS |
10501L106 |
13,989 |
1,602,381 |
SH |
|
SOLE |
1,2,3 |
1,602,381 |
0 |
0 |
| C4 THERAPEUTICS INC |
COM STK |
12529R107 |
109,946 |
4,531,982 |
SH |
|
SOLE |
1,2,3 |
4,531,982 |
0 |
0 |
| CASTLE BIOSCIENCES INC |
COM |
14843C105 |
22,281 |
496,675 |
SH |
|
SOLE |
1,2,3 |
496,675 |
0 |
0 |
| CELLDEX THERAPEUTICS INC NEW |
COM NEW |
15117B202 |
105,048 |
3,084,215 |
SH |
|
SOLE |
1,2,3 |
3,084,215 |
0 |
0 |
| CINCOR PHARMA INC |
COM |
17240Y109 |
24,375 |
1,389,705 |
SH |
|
SOLE |
1,2,3 |
1,389,705 |
0 |
0 |
| CODEX DNA INC |
COM |
192003101 |
1,074 |
200,000 |
SH |
|
SOLE |
1,2,3 |
200,000 |
0 |
0 |
| CONNECT BIOPHARMA HLDGS LTD |
ADS |
207523101 |
1,349 |
446,564 |
SH |
|
SOLE |
1,2,3 |
446,564 |
0 |
0 |
| CUTERA INC |
COM |
232109108 |
105,312 |
1,526,263 |
SH |
|
SOLE |
1,2,3 |
1,526,263 |
0 |
0 |
| CYTOKINETICS INC |
COM NEW |
23282W605 |
94,277 |
2,561,182 |
SH |
|
SOLE |
1,2,3 |
2,561,182 |
0 |
0 |
| CYTOMX THERAPEUTICS INC |
COM |
23284F105 |
15,432 |
5,779,700 |
SH |
|
SOLE |
1,2,3 |
5,779,700 |
0 |
0 |
| DERMTECH INC |
COM |
24984K105 |
45,782 |
3,118,666 |
SH |
|
SOLE |
1,2,3 |
3,118,666 |
0 |
0 |
| ESSA PHARMA INC |
COM NEW |
29668H708 |
16,298 |
2,637,192 |
SH |
|
SOLE |
1,2,3 |
2,637,192 |
0 |
0 |
| ESTABLISHMENT LABS HLDGS INC |
COM |
G31249108 |
156,287 |
2,319,138 |
SH |
|
SOLE |
1,2,3 |
2,319,138 |
0 |
0 |
| EXAGEN INC |
COM |
30068X103 |
7,951 |
990,143 |
SH |
|
SOLE |
1,2,3 |
990,143 |
0 |
0 |
| FULCRUM THERAPEUTICS INC |
COM |
359616109 |
85,405 |
3,611,194 |
SH |
|
SOLE |
1,2,3 |
3,611,194 |
0 |
0 |
| GENETRON HLDGS LTD |
ADS |
37186H100 |
2,626 |
1,198,961 |
SH |
|
SOLE |
1,2,3 |
1,198,961 |
0 |
0 |
| GH RESEARCH PLC |
ORDINARY SHARES |
G3855L106 |
39,670 |
2,168,957 |
SH |
|
SOLE |
1,2,3 |
2,168,957 |
0 |
0 |
| GLOBUS MED INC |
CL A |
379577208 |
124,119 |
1,682,291 |
SH |
|
SOLE |
1,2,3 |
1,682,291 |
0 |
0 |
| GUARDANT HEALTH INC |
COM |
40131M109 |
45,698 |
689,887 |
SH |
|
SOLE |
1,2,3 |
689,887 |
0 |
0 |
| ILLUMINA INC |
COM |
452327109 |
177,976 |
509,375 |
SH |
|
SOLE |
1,2,3 |
509,375 |
0 |
0 |
| IMMATICS N.V |
SHS |
N44445109 |
2,797 |
350,000 |
SH |
|
SOLE |
1,2,3 |
350,000 |
0 |
0 |
| IMMUNIC INC |
COM |
4525EP101 |
30,572 |
2,705,513 |
SH |
|
SOLE |
1,2,3 |
2,705,513 |
0 |
0 |
| IMMUNOCORE HLDGS PLC |
ADS |
45258D105 |
55,598 |
1,859,471 |
SH |
|
SOLE |
1,2,3 |
1,859,471 |
0 |
0 |
| ISOPLEXIS CORP |
COM |
465005106 |
1,252 |
365,000 |
SH |
|
SOLE |
1,2,3 |
365,000 |
0 |
0 |
| ITEOS THERAPEUTICS INC |
COM |
46565G104 |
15,736 |
489,014 |
SH |
|
SOLE |
1,2,3 |
489,014 |
0 |
0 |
| JOHNSON & JOHNSON |
COM |
478160104 |
3,213 |
18,127 |
SH |
|
SOLE |
1,2,3 |
18,127 |
0 |
0 |
| JOUNCE THERAPEUTICS INC |
COM |
481116101 |
31,780 |
4,680,412 |
SH |
|
SOLE |
1,2,3 |
4,680,412 |
0 |
0 |
| LA JOLLA PHARMACEUTICAL CO |
COM PAR $.0001 2 |
503459604 |
9,938 |
2,327,403 |
SH |
|
SOLE |
1,2,3 |
2,327,403 |
0 |
0 |
| LANDOS BIOPHARMA INC |
COM |
515069102 |
6,307 |
4,275,722 |
SH |
|
SOLE |
1,2,3 |
4,275,722 |
0 |
0 |
| MACROGENICS INC |
COM |
556099109 |
35,025 |
3,975,554 |
SH |
|
SOLE |
1,2,3 |
3,975,554 |
0 |
0 |
| MASIMO CORP |
COM |
574795100 |
164,110 |
1,127,593 |
SH |
|
SOLE |
1,2,3 |
1,127,593 |
0 |
0 |
| MAXCYTE INC |
COM |
57777K106 |
1,395 |
199,567 |
SH |
|
SOLE |
1,2,3 |
199,567 |
0 |
0 |
| MEDICUS SCIENCES ACQUISITION |
*W EXP 02/12/202 |
G5960S124 |
14 |
33,331 |
SH |
|
SOLE |
1,2,3 |
33,331 |
0 |
0 |
| MEDICUS SCIENCES ACQUISITION |
CL A SHS |
G5960S108 |
2,934 |
300,000 |
SH |
|
SOLE |
1,2,3 |
300,000 |
0 |
0 |
| MILESTONE PHARMACEUTICALS IN |
COM |
59935V107 |
27,703 |
4,315,102 |
SH |
|
SOLE |
1,2,3 |
4,315,102 |
0 |
0 |
| MINERVA SURGICAL INC |
COM |
60343F106 |
747 |
166,000 |
SH |
|
SOLE |
1,2,3 |
166,000 |
0 |
0 |
| MIRATI THERAPEUTICS INC |
COM |
60468T105 |
128,386 |
1,561,497 |
SH |
|
SOLE |
1,2,3 |
1,561,497 |
0 |
0 |
| MIROMATRIX MED INC |
COM |
60471P108 |
1,109 |
280,000 |
SH |
|
SOLE |
1,2,3 |
280,000 |
0 |
0 |
| MONTE ROSA THERAPEUTICS INC |
COM |
61225M102 |
17,028 |
1,214,572 |
SH |
|
SOLE |
1,2,3 |
1,214,572 |
0 |
0 |
| NANOSTRING TECHNOLOGIES INC |
COM |
63009R109 |
14,040 |
404,029 |
SH |
|
SOLE |
1,2,3 |
404,029 |
0 |
0 |
| NATERA INC |
COM |
632307104 |
77,995 |
1,917,283 |
SH |
|
SOLE |
1,2,3 |
1,917,283 |
0 |
0 |
| NAUTILUS BIOTECHNOLOGY INC |
COM |
63909J108 |
4,774 |
1,100,000 |
SH |
|
SOLE |
1,2,3 |
1,100,000 |
0 |
0 |
| NYXOAH S A |
SHS |
B6S7WD106 |
6,602 |
344,911 |
SH |
|
SOLE |
1,2,3 |
344,911 |
0 |
0 |
| OLINK HLDG AB |
SPONSORED ADS |
680710100 |
17,981 |
1,018,188 |
SH |
|
SOLE |
1,2,3 |
1,018,188 |
0 |
0 |
| OUTSET MED INC |
COM |
690145107 |
40,844 |
899,652 |
SH |
|
SOLE |
1,2,3 |
899,652 |
0 |
0 |
| OYSTER PT PHARMA INC |
COM |
69242L106 |
23,961 |
2,058,504 |
SH |
|
SOLE |
1,2,3 |
2,058,504 |
0 |
0 |
| PENUMBRA INC |
COM |
70975L107 |
147,910 |
665,871 |
SH |
|
SOLE |
1,2,3 |
665,871 |
0 |
0 |
| PMV PHARMACEUTICALS INC |
COM |
69353Y103 |
80,618 |
3,872,154 |
SH |
|
SOLE |
1,2,3 |
3,872,154 |
0 |
0 |
| POINT BIOPHARMA GLOBAL INC |
COM |
730541109 |
3,905 |
490,000 |
SH |
|
SOLE |
1,2,3 |
490,000 |
0 |
0 |
| PROCEPT BIOROBOTICS CORP |
COM |
74276L105 |
5,638 |
161,138 |
SH |
|
SOLE |
1,2,3 |
161,138 |
0 |
0 |
| PROMETHEUS BIOSCIENCES INC |
COM |
74349U108 |
104,140 |
2,757,947 |
SH |
|
SOLE |
1,2,3 |
2,757,947 |
0 |
0 |
| PROQR THRAPEUTICS N V |
SHS EURO |
N71542109 |
6,354 |
7,019,610 |
SH |
|
SOLE |
1,2,3 |
7,019,610 |
0 |
0 |
| PROTAGONIST THERAPEUTICS INC |
COM |
74366E102 |
113,534 |
4,794,499 |
SH |
|
SOLE |
1,2,3 |
4,794,499 |
0 |
0 |
| PTC THERAPEUTICS INC |
COM |
69366J200 |
194,804 |
5,221,228 |
SH |
|
SOLE |
1,2,3 |
5,221,228 |
0 |
0 |
| PULMONX CORP |
COM |
745848101 |
19,805 |
798,255 |
SH |
|
SOLE |
1,2,3 |
798,255 |
0 |
0 |
| PYXIS ONCOLOGY INC |
COMMON STOCK |
747324101 |
8,568 |
2,120,760 |
SH |
|
SOLE |
1,2,3 |
2,120,760 |
0 |
0 |
| QUANTERIX CORP |
COM |
74766Q101 |
36,444 |
1,248,517 |
SH |
|
SOLE |
1,2,3 |
1,248,517 |
0 |
0 |
| REGENXBIO INC |
COM |
75901B107 |
61,248 |
1,845,366 |
SH |
|
SOLE |
1,2,3 |
1,845,366 |
0 |
0 |
| RELMADA THERAPEUTICS INC |
COM |
75955J402 |
68,557 |
2,540,074 |
SH |
|
SOLE |
1,2,3 |
2,540,074 |
0 |
0 |
| RENOVACOR INC |
*W EXP 99/99/999 |
75989E114 |
109 |
350,000 |
SH |
|
SOLE |
1,2,3 |
350,000 |
0 |
0 |
| RENOVACOR INC |
COM |
75989E106 |
12,723 |
3,000,803 |
SH |
|
SOLE |
1,2,3 |
3,000,803 |
0 |
0 |
| RESEARCH ALLIANCE CORP II |
COM CL A |
760873109 |
6,217 |
637,000 |
SH |
|
SOLE |
1,2,3 |
637,000 |
0 |
0 |
| ROCKET PHARMACEUTICALS INC |
COM |
77313F106 |
250,632 |
15,802,802 |
SH |
|
SOLE |
1,2,3 |
15,802,802 |
0 |
0 |
| ROIVANT SCIENCES LTD |
SHS |
G76279101 |
3,965 |
802,717 |
SH |
|
SOLE |
1,2,3 |
802,717 |
0 |
0 |
| RXSIGHT INC |
COM |
78349D107 |
1,857 |
150,000 |
SH |
|
SOLE |
1,2,3 |
150,000 |
0 |
0 |
| SCIENCE 37 HOLDINGS INC |
COM |
808644108 |
21,610 |
4,039,341 |
SH |
|
SOLE |
1,2,3 |
4,039,341 |
0 |
0 |
| SIGHT SCIENCES INC |
COM |
82657M105 |
11,526 |
997,099 |
SH |
|
SOLE |
1,2,3 |
997,099 |
0 |
0 |
| SINGULAR GENOMICS SYSTEMS IN |
COM |
82933R100 |
631 |
100,000 |
SH |
|
SOLE |
1,2,3 |
100,000 |
0 |
0 |
| SOPHIA GENETICS SA |
ORDINARY SHARES |
H82027105 |
1,752 |
226,589 |
SH |
|
SOLE |
1,2,3 |
226,589 |
0 |
0 |
| STOKE THERAPEUTICS INC |
COM |
86150R107 |
76,711 |
3,644,248 |
SH |
|
SOLE |
1,2,3 |
3,644,248 |
0 |
0 |
| SUMMIT HEALTHCRE ACQUISTN CO |
UNIT 06/03/2026 |
G8566R128 |
4,889 |
500,000 |
SH |
|
SOLE |
1,2,3 |
500,000 |
0 |
0 |
| TANDEM DIABETES CARE INC |
COM NEW |
875372203 |
116,864 |
1,004,936 |
SH |
|
SOLE |
1,2,3 |
1,004,936 |
0 |
0 |
| TARSUS PHARMACEUTICALS INC |
COM |
87650L103 |
33,869 |
2,013,601 |
SH |
|
SOLE |
1,2,3 |
2,013,601 |
0 |
0 |
| TELA BIO INC |
COM |
872381108 |
11,834 |
1,017,546 |
SH |
|
SOLE |
1,2,3 |
1,017,546 |
0 |
0 |
| TENAYA THERAPEUTICS INC |
COM |
87990A106 |
28,964 |
2,458,750 |
SH |
|
SOLE |
1,2,3 |
2,458,750 |
0 |
0 |
| THERMO FISHER SCIENTIFIC INC |
COM |
883556102 |
220,312 |
373,000 |
SH |
|
SOLE |
1,2,3 |
373,000 |
0 |
0 |
| ULTRAGENYX PHARMACEUTICAL IN |
COM |
90400D108 |
99,728 |
1,373,284 |
SH |
|
SOLE |
1,2,3 |
1,373,284 |
0 |
0 |
| UROGEN PHARMA LTD |
COM |
M96088105 |
7,469 |
857,464 |
SH |
|
SOLE |
1,2,3 |
857,464 |
0 |
0 |
| VENTYX BIOSCIENCES INC |
COM |
92332V107 |
21,058 |
1,551,778 |
SH |
|
SOLE |
1,2,3 |
1,551,778 |
0 |
0 |
| VERICEL CORP |
COM |
92346J108 |
153,552 |
4,017,570 |
SH |
|
SOLE |
1,2,3 |
4,017,570 |
0 |
0 |
| ZYMERGEN INC |
COM |
98985X100 |
202 |
70,000 |
SH |
|
SOLE |
1,2,3 |
70,000 |
0 |
0 |
Tweet
Share
E-mail
